BNP Paribas Asset Management
IRWD icon

BNP Paribas Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

BNP Paribas Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Hold
375,288
– – ﹤0.01% 1145
2026
Q1 		$1.32M Buy
+375,288
New +$1.54M ﹤0.01% 1127
2020
Q3 		– Sell
-1,264,796
Closed -$13.1M – 833
2020
Q2 		$13.1M Sell
1,264,796
-634,814
-33% -$6.5M 0.09% 254
2020
Q1 		$19.2M Sell
1,899,610
-4,619
-0.2% -$54.3K 0.16% 172
2019
Q4 		$25.3M Buy
1,904,229
+511,860
+37% +$5.64M 0.17% 166
2019
Q3 		$12M Buy
1,392,369
+553,859
+66% +$5.38M 0.09% 267
2019
Q2 		$9.17M Buy
838,510
+53,183
+7% +$596K 0.07% 311
2019
Q1 		$8.9M Buy
785,327
+190,112
+32% +$2.12M 0.07% 324
2018
Q4 		$4.94M Sell
595,215
-816,837
-58% -$9.37M 0.05% 447
2018
Q3 		$21.8M Sell
1,412,052
-204,316
-13% -$3.23M 0.17% 171
2018
Q2 		$25.9M Sell
1,616,368
-419,371
-21% -$6.21M 0.22% 121
2018
Q1 		$26.3M Sell
2,035,739
-146,128
-7% -$1.82M 0.22% 126
2017
Q4 		$27.4M Buy
2,181,867
+16,550
+0.8% +$216K 0.23% 103
2017
Q3 		$28.6M Buy
2,165,317
+839,496
+63% +$11.6M 0.24% 93
2017
Q2 		$21M Sell
1,325,821
-86,478
-6% -$1.26M 0.19% 124
2017
Q1 		$20.2M Buy
1,412,299
+133,064
+10% +$1.82M 0.19% 125
2016
Q4 		$16.4M Buy
1,279,235
+465,132
+57% +$5.87M 0.16% 161
2016
Q3 		$10.8M Buy
+814,103
New +$9.52M 0.09% 299

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

BNP Paribas Asset Management's IRWD Position: Q2 2026 in Review

BNP Paribas Asset Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 375,288 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

BNP Paribas Asset Management first reported a position in IRWD in Q3 2016 and has held it in 18 quarters since. The position peaked at $28.6M in Q3 2017. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • BNP Paribas Asset Management held 375,288 shares of Ironwood Pharmaceuticals worth $1.58M as of Q2 2026.
  • BNP Paribas Asset Management left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1145 holding.
  • BNP Paribas Asset Management first reported a position in Ironwood Pharmaceuticals in Q3 2016 and has held it in 18 quarters since.
  • BNP Paribas Asset Management's Ironwood Pharmaceuticals position peaked at $28.6M in Q3 2017.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.